Is BCL-2 a Predictive Marker of Neoadjuvant Chemotherapy Response in Patients With Urothelial Bladder Cancer Undergoing Radical Cystectomy?

Scandinavian Journal of Urology - United Kingdom
doi 10.1080/21681805.2019.1575467
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Neoadjuvant Chemotherapy Prior to Radical Cystectomy for Muscle-Invasive Bladder Cancer With Variant Histology

Cancer
Cancer ResearchOncology
2017English

Efficient Delivery of Radical Cystectomy After Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer

Cancer
Cancer ResearchOncology
2011English

Overexpression of RNF2 Is an Independent Predictor of Outcome in Patients With Urothelial Carcinoma of the Bladder Undergoing Radical Cystectomy

Scientific Reports
Multidisciplinary
2016English

Adjuvant Chemotherapy Versus Observation After Radical Cystectomy in Patients With Node-Positive Bladder Cancer

Scientific Reports
Multidisciplinary
2019English

Suboptimal Use of Neoadjuvant Chemotherapy in Radical Cystectomy Patients: A Population-Based Study

Canadian Urological Association Journal
Urology
2016English

A Study on 52 Patients With Bladder Cancer Treated With Radical Cystectomy

Japanese Journal of Urology
Urology
1986English

Lower Skeletal Muscle Index and Early Complications in Patients Undergoing Radical Cystectomy for Bladder Cancer

World Journal of Surgical Oncology
SurgeryOncology
2014English

BCL-2 Expression as a Predictive Marker of Hormone-Refractory Prostate Cancer Treated With Taxane-Based Chemotherapy

Clinical Cancer Research
Cancer ResearchOncology
2006English

Clinicopathological Characteristics of ypT0N0 Urothelial Carcinoma Following Neoadjuvant Chemotherapy and Cystectomy

Journal of Clinical Pathology
MedicineForensic MedicinePathology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy